Central Indiana Cancer Centers is a clinical research site located in Indianapolis, Indiana, United States 46219.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Central Indiana Cancer Centers has participated in 37 clinical trials.
Therapeutic areas: Neoplasms, Rectal Cancer, Gastric Cancer Adenocarcinoma Metastatic.
Sponsors: Adherex Technologies, Inc., US Oncology Research, Eisai Inc..
Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Central Indiana Cancer Centers has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Indiana Cancer Centers has 37 clinical trials on record. Their work covers Neoplasms, Rectal Cancer, Gastric Cancer Adenocarcinoma Metastatic.
Yes — Central Indiana Cancer Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.